Ennis & Ennis, P.A.

Over 10,000 women have filed claims based on injuries received from Yaz, Yasmin and Ocella birth control pills, making it one of the largest mass torts in recent history.

In the first trial against Johnson & Johnson’s Ethicon unit, maker of the Gynecare Prolift vaginal mesh, testimony has revealed that Ethicon ignored warnings, from both internal and outside sources about potential dangers of the mesh.

The Food and Drug Administration (FDA) issued a Safety Communication on January 17, 2013 to the medical community and patients who are considering or have received a metal-on-metal hip implant, warning of the unique risks of all-metal implants.

This article is to provide users of the Mirena IUD information regarding why you may be entitled to compensation for injuries caused by this dangerous device.

Merck & Co., the manufacturers of the popular osteoporosis drug Fosamax, suffered a defeat during the last bellwether trial in multidistrict litigation alleging that Fosamax causes jaw bone deterioration.

Despite assertions by Johnson & Johnson (J&J) that it withdrew its DePuy ASR hip implants from the market due to financial performance, its designer testified before a Los Angeles jury that the devices were actually pulled due to safety concerns.

Plaintiffs who lost loved ones due to GranuFlo side effects have filed lawsuits against Fresenius Medical Care, the manufacturer of GranuFlo and NaturaLyte dialysis products.

Internal documents disclosed in trial revealed that J&J knew several years before the device was recalled that the ASR’s defective design caused it to shed large quantities of metal debris.

According to newly unsealed court records, an internal analysis conducted by J&J shortly after it recalled its troubled DePuy ASR hip implant, estimated that 37 percent of the devices would fail with the first five years.

The first transvaginal mesh multi-district litigation (MDL) case is set for trial on February 5, 2013 and names American Medical Systems as defendant.